NGC Update Service: March 7, 2016

National Guideline Clearinghouse (NGC)

March 7, 2016

New This Week

Guideline Synthesis

Guideline Summaries

American Cancer Society

National Collaborating Centre for Women's and Children's Health

Program in Evidence-based Care

U.S. Preventive Services Task Force

Withdrawn Summaries

The summaries listed below have been withdrawn from the NGC Web site because they no longer meet the NGC Inclusion Criteria. See the Guideline Archive for a complete list of guidelines that have been withdrawn from the NGC Web site.

American Association for the Study of Liver Diseases

  • An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.

National Clinical Guideline Centre for Acute and Chronic Conditions

  • Alcohol-use disorders. Diagnosis and clinical management of alcohol-related physical complications.
  • Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin.
  • Chronic heart failure. Management of chronic heart failure in adults in primary and secondary care.
  • Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care.
  • Delirium: diagnosis, prevention and management.
  • Nocturnal enuresis: the management of bedwetting in children and young people.
  • Transient loss of consciousness ('blackouts') management in adults and young people.
  • Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction.

National Clinical Guideline Centre

  • Sedation in children and young people. Sedation for diagnostic and therapeutic procedures in children and young people.

National Collaborating Centre for Cancer

  • Metastatic malignant disease of unknown primary origin. Diagnosis and management of metastatic malignant disease of unknown primary origin.

National Collaborating Centre for Women's and Children's Health

  • Bacterial meningitis and meningococcal septicaemia. Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care.
  • Constipation in children and young people. Diagnosis and management of idiopathic childhood constipation in primary and secondary care.
  • Hypertension in pregnancy. The management of hypertensive disorders during pregnancy.
  • Neonatal jaundice.
  • Pregnancy and complex social factors. A model for service provision for pregnant women with complex social factors.

National Institute for Health and Care Excellence (NICE)

  • Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor.
  • Barrett's oesophagus. Ablative therapy for the treatment of Barrett's oesophagus.
  • Capecitabine for the treatment of advanced gastric cancer.
  • Certolizumab pegol for the treatment of rheumatoid arthritis.
  • Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events.
  • Denosumab for the prevention of osteoporotic fractures in postmenopausal women.
  • Donor breast milk banks: the operation of donor milk bank services.
  • Dronedarone for the treatment of non-permanent atrial fibrillation.
  • Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis.
  • Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer.
  • Human growth hormone (somatropin) for the treatment of growth failure in children.
  • Infliximab (review) and adalimumab for the treatment of Crohn's disease.
  • Liraglutide for the treatment of type 2 diabetes mellitus.
  • Motor neurone disease. The use of non-invasive ventilation in the management of motor neurone disease.
  • Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab.
  • Pemetrexed for the maintenance treatment of non-small-cell lung cancer.
  • Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia.
  • Sorafenib for the treatment of advanced hepatocellular carcinoma.
  • Trabectedin for the treatment of advanced soft tissue sarcoma.

Announcements

Conference News

  • The Guidelines International Network (G-I-N) 13th annual conference will take place from September 27-30, 2016 in Philadelphia. This conference will be co-hosted by the American College of Physicians, ECRI Institute and Penn Medicine. The theme is "Individualised Guidelines and Clinical Performance Measurement in an Era of Personalised Medicine." Abstract submission and registration now open. For more information, visit the G-I-N Conference Web site.
  • The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, are available on the G-I-N Web site.

NGC Spotlight

  • New research review added! Visit the AHRQ Evidence Reports page for a listing of summary guides and research reviews produced under AHRQ's Effective Health Care Program.

Health Awareness Topics - March 2016

How to Participate

  • Submit Guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
  • Suggest a Guideline for Possible Inclusion: Submit your suggestions for evidence-based clinical practice guidelines that you would like to see included in NGC.

NGC's Sister Resource